ArticleGlobal heart2024
Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data.
Abstract readLetter
In one paragraph
Article in Global heart, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Reciprocal Relationship Between Cardiovascular Risk and Attainment of Blood Pressure and Cholesterol Targets in Users of a Mobile Health App.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026Article
- Associations between use of aspirin and magnetic resonance imaging-derived liver fat and fibroinflammation.Diabetes, obesity & metabolism · 2026Article
- Global research trends and hotspots in aspirin studies (2014-2024): a bibliometric perspective.Frontiers in pharmacology · 2025Review
- Effect of aspirin use on conversion risk from mild cognitive impairment to Alzheimer's disease.Frontiers in aging neuroscience · 2025Article
- Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges.Frontiers in pharmacology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors.
Sang Gune K YooCardiovascular Division, Department of Internal Medicine, Washington University in St Louis, St Louis, MO, USA.ORCID 0009-0003-8281-0743
Grace S ChungDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-1818-0148
Silver K BahendekaDepartment of Internal Medicine, MKPGMS Uganda Martyrs University, Kampala.
Abla M SibaiEpidemiology and Population Health Department, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon.ORCID 0000-0002-1851-5606
Albertino DamascenoFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.ORCID 0000-0003-0925-494X
Farshad FarzadfarNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Peter RohloffCenter for Indigenous Health Research, Wuqu'Kawoq, Tecpán, Guatemala.
Corine HouehanouLaboratory of Epidemiology of Chronic and Neurological Diseases, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin.
Bolormaa NorovNutrition Department, National Center for Public Health, Ulaanbaatar, Mongolia.ORCID 0000-0001-8074-9393
Khem B KarkiDepartment of Community Medicine and Public Health, Institute of Medicine, Tribhuvan University, Kathmandu, Nepal.
Mohammadreza Azangou-KhyavyNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maja E MarcusDivision of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-4904-2087
Krishna K AryalBergen Centre for Ethics and Priority Setting in Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.ORCID 0000-0003-0801-0775
Luisa C C BrantDepartamento de Clínica Médica, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0002-7317-1367
Michaela TheilmannHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Renata CífkováCenter for Cardiovascular Prevention, First Faculty of Medicine and Thomayer University Hospital, Charles University in Prague, Prague, Czechia.ORCID 0000-0003-2765-3821
Nuno LunetDepartment of Public Health and Forensic Health Sciences and Medical Education, Faculty of Medicine, University of Porto, Porto, Portugal.
Mongal S GurungHealth Research and Epidemiology Unit, Ministry of Health, Thimphu, Bhutan.ORCID 0000-0001-6481-6242
Joseph Kibachio MwangiDivision of Non-Communicable Diseases, Ministry of Health, Nairobi, Kenya.
Joao MartinsFaculty of Medicine and Health Sciences, Universidade Nacional Timor Lorosa'e, Dili, Timor-Leste.
Rosa HaghshenasNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Lela SturuaNon-Communicable Disease Department, National Center for Disease Control and Public Health, Tbilisi, Georgia.ORCID 0000-0002-8242-1145
Sebastian VollmerDepartment of Economics & Centre for Modern Indian Studies, University of Goettingen, Göttingen, Germany.
Till BärnighausenHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Rifat AtunDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.ORCID 0000-0002-1531-5983
Jeremy B SussmanDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Kavita SinghHeidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Sahar Saeedi MoghaddamEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-3112-9179
David GuwatuddeDepartment of Epidemiology and Biostatistics, School of Public Health, Makerere University, Kampala, Uganda.
Pascal GeldsetzerDivision of Primary Care and Population Health, Stanford University, USA.ORCID 0000-0002-8878-5505
Jennifer Manne-GoehlerDivision of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Mark D HuffmanDepartment of Medicine and Global Health Center, Washington University in St Louis, St Louis, MO, USA.ORCID 0000-0001-7412-2519
Justine I DaviesInstitute for Applied Health Research, University of Birmingham, UK.
David FloodDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-4372-7387
Funding
Research Education CoreP30AG024824 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Lona Mody, RAYMOND L YUNG · 2004 to 2026
$29.2MResearch BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0MImplementation research for comprehensive cardiometabolic care in GuatemalaK23HL161271 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Clifford Flood · 2022 to 2026
$949kNHLBI NIH HHS K23 HL161271NIA NIH HHS P30 AG024824NIDDK NIH HHS P30 DK092926
Abstract
PubMed holds no abstract for this paper.
Indexed as
AspirinCardiovascular DiseasesGlobal HealthPrimary PreventionAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedPlatelet Aggregation InhibitorsPrevalenceAspirinPlatelet Aggregation Inhibitorsaspirincardiovascular diseasenon-communicable diseaseprevention
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.